These modern medications, like copyright and Semaglutide, represent a groundbreaking class of drugs called GLP-1 receptor mimics. This class of medications work by increasing the body's own ability to release GLP-1, a hormone that helps manage sugar levels and appetite. Initially, designed for managing type 2 high blood sugar, they have also shown